Measurement of ceftolozane and tazobactam concentrations in plasma by UHPLC-MS/MS. Clinical application in the management of difficult-to-treat osteoarticular infections-Reference-Cited by-同舟云学术

Measurement of ceftolozane and tazobactam concentrations in plasma by UHPLC-MS/MS. Clinical application in the management of difficult-to-treat osteoarticular infections

Published:2019-01 Issue: Volume:488 Page:50-60
ISSN:0009-8981
Container-title:Clinica Chimica Acta
language:en
Short-container-title:Clinica Chimica Acta

Author:

Rigo-Bonnin Raúl,Gomez-Junyent Joan,García-Tejada Laura,Benavent Eva,Soldevila Laura,Tubau Fe,Murillo Oscar

Funder

Instituto de Salud Carlos III

Merck Sharp & Dohme

Publisher

Elsevier BV

Subject

Biochemistry (medical),Clinical Biochemistry,Biochemistry,General Medicine

Reference34 articles.

1. Multidrug-resistant pseudomonas infections: hard to treat, but hope on the horizon?;Nguyen;Curr. Infect. Dis. Rep.,2018

2. How to manage Pseudomonas aeruginosa infections;Bassetti;Drugs Context,2018

3. Ceftolozane/tazobactam: a novel cephalosporin/β-lactamase inhibitor combination with activity against multidrug-resistant gram-negative bacilli;Zhanel;Drugs,2014

4. Osteoarticular infection caused by MDR Pseudomonas aeruginosa: the benefits of combination therapy with colistin plus β-lactams;Ribera;J. Antimicrob. Chemother.,2015

5. ESCMID guideline for the diagnosis and treatment of biofilm infections 2014;Hoiby;Clin. Microbiol. Infect.,2015

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preanalytical Stability of Flucloxacillin, Piperacillin, Tazobactam, Meropenem, Cefalexin, Cefazolin, and Ceftazidime in Therapeutic Drug Monitoring: A Structured Review;Therapeutic Drug Monitoring;2022-12

2. UPLC Technique in Pharmacy—An Important Tool of the Modern Analyst;Processes;2022-11-24

3. Evaluation of 4 quantification methods for monitoring 16 antibiotics and 1 beta-lactamase inhibitor in human serum by high-performance liquid chromatography with tandem mass spectrometry detection;Journal of Pharmaceutical and Biomedical Analysis;2022-09

4. A validated LC-MS/MS method for the simultaneous quantification of the novel combination antibiotic, ceftolozane–tazobactam, in plasma (total and unbound), CSF, urine and renal replacement therapy effluent: application to pilot pharmacokinetic studies;Clinical Chemistry and Laboratory Medicine (CCLM);2020-11-25

5. Development and validation of a quantitative LC-MS/MS method for the simultaneous determination of ceftolozane and tazobactam in human plasma and urine;Journal of Chromatography B;2020-11